Markers of acute myeloid leukemia stem cells (AMLSC) are identified. The markers are differentially expressed in comparison with normal counterpart cells, and are useful as diagnostic and therapeutic targets.
Edits on 20 May, 2023
"Remove website redirecting to Patent Public Search front page"